Mutual of America Capital Management LLC Has $25.36 Million Stock Position in Danaher Co. (NYSE:DHR)

Mutual of America Capital Management LLC raised its holdings in Danaher Co. (NYSE:DHR) by 0.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 83,296 shares of the conglomerate’s stock after buying an additional 578 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Danaher were worth $25,359,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of DHR. Guidance Point Advisors LLC acquired a new position in Danaher in the third quarter valued at approximately $25,000. D Orazio & Associates Inc. acquired a new position in Danaher in the third quarter valued at approximately $27,000. Alaethes Wealth LLC acquired a new position in Danaher in the second quarter valued at approximately $32,000. JFS Wealth Advisors LLC lifted its stake in Danaher by 53.3% in the third quarter. JFS Wealth Advisors LLC now owns 115 shares of the conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the period. Finally, Penserra Capital Management LLC acquired a new position in Danaher in the second quarter valued at approximately $40,000. 82.59% of the stock is currently owned by hedge funds and other institutional investors.

In other news, Director Linda P. Hefner sold 2,185 shares of the firm’s stock in a transaction that occurred on Thursday, November 11th. The stock was sold at an average price of $303.72, for a total value of $663,628.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Mitchell P. Rales sold 343,862 shares of the firm’s stock in a transaction that occurred on Thursday, November 4th. The shares were sold at an average price of $305.85, for a total value of $105,170,192.70. The disclosure for this sale can be found here. Over the last quarter, insiders sold 750,719 shares of company stock worth $233,160,046. Corporate insiders own 11.40% of the company’s stock.

DHR traded down $1.13 on Friday, hitting $290.92. 105,358 shares of the company were exchanged, compared to its average volume of 2,720,081. The firm has a fifty day simple moving average of $312.64 and a two-hundred day simple moving average of $307.81. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.11 and a current ratio of 1.48. Danaher Co. has a 12 month low of $211.22 and a 12 month high of $333.96. The stock has a market capitalization of $207.89 billion, a PE ratio of 37.02, a price-to-earnings-growth ratio of 1.37 and a beta of 0.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, October 20th. The conglomerate reported $2.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.24. Danaher had a return on equity of 18.32% and a net margin of 20.97%. The business had revenue of $7.20 billion for the quarter, compared to analyst estimates of $7 billion. During the same period last year, the company earned $1.72 EPS. Danaher’s revenue for the quarter was up 22.0% compared to the same quarter last year. On average, equities analysts expect that Danaher Co. will post 9.86 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 28th. Stockholders of record on Thursday, December 30th will be given a $0.21 dividend. The ex-dividend date is Wednesday, December 29th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.29%. Danaher’s dividend payout ratio is currently 10.65%.

Several equities analysts have issued reports on DHR shares. Citigroup boosted their price target on Danaher from $345.00 to $370.00 and gave the company a “buy” rating in a research note on Friday, October 22nd. Royal Bank of Canada upped their target price on Danaher from $332.00 to $334.00 and gave the stock a “sector perform” rating in a research report on Friday, October 22nd. Barclays upped their target price on Danaher from $335.00 to $355.00 and gave the stock an “overweight” rating in a research report on Friday, October 22nd. Robert W. Baird upped their target price on Danaher from $305.00 to $340.00 and gave the stock an “outperform” rating in a research report on Friday, October 22nd. Finally, Wells Fargo & Company upped their target price on Danaher from $340.00 to $350.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 14th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Buy” and a consensus price target of $341.07.

About Danaher

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines.

Featured Story: Front-End Load

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.